Lecanemab (Leqembi®) carries an important boxed warning

By Vimal Aga MD (bio) and Rajnish Mago MD (bio) In other articles on this website (please see Related Pages below), we have discussed anti-amyloid beta antibodies that have been developed as “disease-modifying” treatments for the early stages of Alzheimer’s disease Lecanemab (Leqembi®) carries a “boxed warning” (often wrongly called a “black box warning”). This…